Insider · CIK 0001650737
Jeremy B. Hayden
officer
Files at SGHT (Sight Sciences, Inc.). First filing Jan 6, 2025, latest Nov 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $522k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGHT: Sight Sciences, Inc.
SGHTOct 9, 2026 · close 8.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Sight Sciences, Inc. | $362k 44,850 shares | -15% | +288% from low0% from high | |
| 0Weak | Sight Sciences, Inc. | $25k 3,150 shares | -1% | +269% from low0% from high | |
| 35Weak | Sight Sciences, Inc. | $32k 9,731 shares | -4% | +57% from low-47% from high | |
| 36Weak | Sight Sciences, Inc. | $38k 9,160 shares | -3% | +101% from low-39% from high | |
| 30Weak | Sight Sciences, Inc. | $22k 9,395 shares | -3% | 0% from low-68% from high | |
| 30Weak | Sight Sciences, Inc. | $19k 6,922 shares | -5% | - | |
| 30Weak | Sight Sciences, Inc. | $5,899 1,810 shares | -1% | - | |
| 30Weak | Sight Sciences, Inc. | $17k 4,864 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock10b5-1 | +37,560 | $1.96 | $74k | 294,150 | Nov 26, 2025 |
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock10b5-1 | +7,290 | $1.96 | $14k | 301,440 | Nov 26, 2025 |
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -44,850 | $8.08 | $362k | 256,590 | Nov 26, 2025 |
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -37,560 | $0.00 | $0 | 40,000 | Nov 26, 2025 |
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,290 | $0.00 | $0 | 8,000 | Nov 26, 2025 |
| Nov 12, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock10b5-1 | +2,440 | $1.96 | $4,782 | 259,030 | Nov 14, 2025 |
| Nov 12, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Common Stock10b5-1 | +710 | $1.96 | $1,392 | 259,740 | Nov 14, 2025 |
| Nov 12, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,150 | $8.01 | $25k | 256,590 | Nov 14, 2025 |
| Nov 12, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,440 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Nov 12, 2025 | SGHT Sight Sciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -710 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Oct 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -9,731 | $3.27 | $32k | 256,590 | Oct 3, 2025 |
| Jul 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -9,160 | $4.17 | $38k | 266,321 | Jul 7, 2025 |
| Apr 2, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -9,395 | $2.31 | $22k | 275,481 | Apr 3, 2025 |
| Mar 11, 2025 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +139,785 | $0.00 | $0 | 284,876 | Mar 13, 2025 |
| Jan 17, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -6,922 | $2.78 | $19k | 145,091 | Jan 21, 2025 |
| Jan 8, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -1,810 | $3.26 | $5,899 | 152,013 | Jan 10, 2025 |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -4,864 | $3.52 | $17k | 153,823 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.